Prevalence of Hepatitis E Virus Antibodies Among Blood Donors: A Systematic Review and Meta-Analysis

Authors Information
Article Notes and Dates
To Cite : Ferreira V L, Souza V R D, Araujo Muzzillo D, Pontarolo R. Prevalence of Hepatitis E Virus Antibodies Among Blood Donors: A Systematic Review and Meta-Analysis, Hepat Mon. 2017 ;17(7):e42875. doi: 10.5812/hepatmon.42875.
Copyright: Copyright © 2017, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
Abstract
1. Context
2. Methods
3. Results
4. Discussion
Footnotes
References
  • 1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2095-128[DOI][PubMed]
  • 2. Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology. 2012; 55(4): 988-97[DOI][PubMed]
  • 3. Ben-Ayed Y, Hannachi H, Ben-Alaya-Bouafif N, Gouider E, Triki H, Bahri O. Hepatitis E virus seroprevalence among hemodialysis and hemophiliac patients in Tunisia (North Africa). J Med Virol. 2015; 87(3): 441-5[DOI][PubMed]
  • 4. Fischer C, Hofmann M, Danzer M, Hofer K, Kaar J, Gabriel C. Seroprevalence and Incidence of hepatitis E in blood donors in Upper Austria. PLoS One. 2015; 10(3)[DOI][PubMed]
  • 5. Dreier J, Juhl D. Autochthonous hepatitis e virus infections: a new transfusion-associated risk? Transfus Med Hemother. 2014; 41(1): 29-39[DOI][PubMed]
  • 6. Ehteram H, Ramezani A, Eslamifar A, Sofian M, Banifazl M, Ghassemi S, et al. Seroprevalence of Hepatitis E Virus infection among volunteer blood donors in central province of Iran in 2012. Iran J Microbiol. 2013; 5(2): 172-6[PubMed]
  • 7. Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B, et al. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet. 2014; 384(9956): 1766-73[DOI][PubMed]
  • 8. Matsubayashi K, Nagaoka Y, Sakata H, Sato S, Fukai K, Kato T, et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion. 2004; 44(6): 934-40[DOI][PubMed]
  • 9. Matsubayashi K, Kang JH, Sakata H, Takahashi K, Shindo M, Kato M, et al. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion. 2008; 48(7): 1368-75[DOI][PubMed]
  • 10. Boxall E, Herborn A, Kochethu G, Pratt G, Adams D, Ijaz S, et al. Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. Transfus Med. 2006; 16(2): 79-83[DOI][PubMed]
  • 11. Hauser L, Roque-Afonso AM, Beyloune A, Simonet M, Deau Fischer B, Burin des Roziers N, et al. Hepatitis E transmission by transfusion of Intercept blood system-treated plasma. Blood. 2014; 123(5): 796-7[DOI][PubMed]
  • 12. Adlhoch C, Kaiser M, Pauli G, Koch J, Meisel H. Indigenous hepatitis E virus infection of a plasma donor in Germany. Vox Sang. 2009; 97(4): 303-8[DOI][PubMed]
  • 13. Colson P, Coze C, Gallian P, Henry M, De Micco P, Tamalet C. Transfusion-associated hepatitis E, France. Emerg Infect Dis. 2007; 13(4): 648-9[DOI][PubMed]
  • 14. Matsui T, Kang JH, Matsubayashi K, Yamazaki H, Nagai K, Sakata H, et al. Rare case of transfusion-transmitted hepatitis E from the blood of a donor infected with the hepatitis E virus genotype 3 indigenous to Japan: Viral dynamics from onset to recovery. Hepatol Res. 2015; 45(6): 698-704[DOI][PubMed]
  • 15. Mirazo S, Ramos N, Mainardi V, Gerona S, Arbiza J. Transmission, diagnosis, and management of hepatitis E: an update. Hepat Med. 2014; 6: 45-59[DOI][PubMed]
  • 16. Perez-Gracia MT, Suay B, Mateos-Lindemann ML. Hepatitis E: an emerging disease. Infect Genet Evol. 2014; 22: 40-59[DOI][PubMed]
  • 17. Fujiwara S, Yokokawa Y, Morino K, Hayasaka K, Kawabata M, Shimizu T. Chronic hepatitis E: a review of the literature. J Viral Hepat. 2014; 21(2): 78-89[DOI][PubMed]
  • 18. Aggarwal R. Diagnosis of hepatitis E. Nat Rev Gastroenterol Hepatol. 2013; 10(1): 24-33[DOI][PubMed]
  • 19. World Health Organization (WHO). . A systematic review on hepatitis E virus globally. 2014;
  • 20. Naeimi B, Mazloom Kalimani F, Pourfatolah AA, Azimzadeh M, Mankhian A, Akbarzadeh S, et al. Hepatitis E Virus Seroprevalence Among Blood Donors in Bushehr, South of Iran. Hepat Mon. 2015; 15(11)[DOI][PubMed]
  • 21. Hesamizadeh K, Sharafi H, Keyvani H, Alavian SM, Najafi-Tireh Shabankareh A, Sharifi Olyaie R, et al. Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran. Hepat Mon. 2016; 16(1)[DOI][PubMed]
  • 22. Hayden JA, Cote P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med. 2006; 144(6): 427-37[DOI][PubMed]
  • 23. Ahmed A, Ali IA, Ghazal H, Fazili J, Nusrat S. Mystery of hepatitis e virus: recent advances in its diagnosis and management. Int J Hepatol. 2015; 2015: 872431[DOI][PubMed]
  • 24. Zhuang W, Ding X, Lyu C, Xiang L, Teng H, Li J. Hepatitis E virus seroprevalence among blood donors in Jiangsu Province, East China. Int J Infect Dis. 2014; 26: 9-11[DOI][PubMed]
  • 25. Hepatitis E emerges as a significant cause of liver inflammation worldwide. 10th International symposium on viral hepatitis and liver diseases.
  • 26. Folgado Alberto S, Pires S, Félix J, Figueiredo A, Silva L, Franco M. Prevalence of Hepatitis E virus in a non endemic population-prospective study. GE-J Port Gastrenterol. 2009; 16: 191-7
  • 27. Mansuy JM, Legrand-Abravanel F, Calot JP, Peron JM, Alric L, Agudo S, et al. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J Med Virol. 2008; 80(2): 289-93[DOI][PubMed]
  • 28. van der Poel WH, Verschoor F, van der Heide R, Herrera MI, Vivo A, Kooreman M, et al. Hepatitis E virus sequences in swine related to sequences in humans, The Netherlands. Emerg Infect Dis. 2001; 7(6): 970-6[DOI][PubMed]
  • 29. Abe K, Li TC, Ding X, Win KM, Shrestha PK, Quang VX, et al. International collaborative survey on epidemiology of hepatitis E virus in 11 countries. Southeast Asian J Trop Med Public Health. 2006; 37(1): 90-5[PubMed]
  • 30. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis. 2008; 8(11): 698-709[DOI][PubMed]
  • 31. Pawlotsky JM. Hepatitis E screening for blood donations: an urgent need? Lancet. 2014; 384(9956): 1729-30[DOI][PubMed]
  • 32. Haim-Boukobza S, Ferey MP, Vetillard AL, Jeblaoui A, Pelissier E, Pelletier G, et al. Transfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity. J Hepatol. 2012; 57(6): 1374-8[DOI][PubMed]
  • 33. Anand AC, Singh KJ, Sharma P, Kumar S, Gupta RM. Incidence of Hepatitis E Virus Infection in Recipients of Blood or Blood Products Transfusion. Med J Armed Forces India. 2010; 66(3): 204-7[DOI][PubMed]
  • 34. Parsa R, Adibzadeh S, Behzad Behbahani A, Farhadi A, Yaghobi R, Rafiei Dehbidi GR, et al. Detection of Hepatitis E Virus Genotype 1 Among Blood Donors From Southwest of Iran. Hepat Mon. 2016; 16(6)[DOI][PubMed]
  • 35. Favorov MO, Fields HA, Purdy MA, Yashina TL, Aleksandrov AG, Alter MJ, et al. Serologic identification of hepatitis E virus infections in epidemic and endemic settings. J Med Virol. 1992; 36(4): 246-50[PubMed]
  • 36. Paul DA, Knigge MF, Ritter A, Gutierrez R, Pilot-Matias T, Chau KH, et al. Determination of hepatitis E virus seroprevalence by using recombinant fusion proteins and synthetic peptides. J Infect Dis. 1994; 169(4): 801-6[PubMed]
  • 37. Aminiafshar S, Alimagham M, Gachkar L, Yousefi F, Attarchi Z. Anti hepatitis E virus seropositivity in a group of blood donors. Iran J Public Health. 2004; 33(4): 53-6
  • 38. Assarehzadegan MA, Shakerinejad G, Amini A, Rezaee SA. Seroprevalence of hepatitis E virus in blood donors in Khuzestan Province, southwest Iran. Int J Infect Dis. 2008; 12(4): 387-90[DOI][PubMed]
  • 39. Juhl D, Baylis SA, Blumel J, Gorg S, Hennig H. Seroprevalence and incidence of hepatitis E virus infection in German blood donors. Transfusion. 2014; 54(1): 49-56[DOI][PubMed]
  • 40. Kaufmann A, Kenfak-Foguena A, Andre C, Canellini G, Burgisser P, Moradpour D, et al. Hepatitis E virus seroprevalence among blood donors in southwest Switzerland. PLoS One. 2011; 6(6)[DOI][PubMed]
  • 41. Takeda H, Matsubayashi K, Sakata H, Sato S, Kato T, Hino S, et al. A nationwide survey for prevalence of hepatitis E virus antibody in qualified blood donors in Japan. Vox Sang. 2010; 99(4): 307-13[DOI][PubMed]
  • 42. Houcine N, Jacques R, Salma F, Anne-Gaelle D, Amin S, Mohsen H, et al. Seroprevalence of hepatitis E virus infection in rural and urban populations, Tunisia. Clin Microbiol Infect. 2012; 18(5)-21[DOI][PubMed]
  • 43. Meng XJ, Wiseman B, Elvinger F, Guenette DK, Toth TE, Engle RE, et al. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol. 2002; 40(1): 117-22[DOI][PubMed]
  • 44. Avellon A, Morago L, Garcia-Galera del Carmen M, Munoz M, Echevarria JM. Comparative sensitivity of commercial tests for hepatitis E genotype 3 virus antibody detection. J Med Virol. 2015; 87(11): 1934-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check